Select Page

CURRENT TRIALS

We are currently performing several studies on RA, Psoriatic Arthritis, and Lupus. Summaries of several of these studies can be found on the FDA database of research studies known as ClinicalTrials.gov. The specific links are as follows…

 

RA (Rheumatoid Arthritis)

  • Study 1 – Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate.
  • Study 2 – Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs)
  • Study 3 – A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis (RA-BRIDGE)

SLE (Systemic Lupus Erythematosus)

  • Study 1 – A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (BRAVE II)
  • Study 2 – A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) (SLE-BRAVE-X)

Psoriatic Arthritis

  • Study 1 – A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Tildrakizumab in Anti-TNF Experienced Subjects with Active Psoriatic Arthritis I (INSPIRE 1)

About Us

Cincinnati Rheumatic Disease Study Group
10495 Montgomery Road, Suite 26
Cincinnati, OH 45242
(513) 559-2130

Connect With Us

1000 Patients Helped by 18 Rheumatologists Since 1991!

Copyright ©2019 - Cincinnati Rheumatic Disease Study Group. All rights reserved. Internet Presence by Main Street Marketing

About Us

Cincinnati Rheumatic Disease Study Group
10495 Montgomery Road, Suite 26
Cincinnati, OH 45242
(513) 559-2130

Connect With Us

1000 Patients Helped by 18 Rheumatologists Since 1991!

 

Copyright ©2019 - Cincinnati Rheumatic Disease Study Group. All rights reserved.
Internet Presence by Main Street Marketing